Concepedia

Amal Helmy

AH

Statistics

Publications

6

Citations

132

H-Index

6

Active since

2015

Affiliations

Tanta University(Current)

Tanta University Hospital

Alexandria University

Amal Helmy is an author at Tanta University specializing in medicine, clinical chemistry, and chronic kidney disease.

Top concepts

Publications per year

2015–2021

6

Publications

6

Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients

Fatma Elgebaly, Sabry Abou-Saif, Mahmoud Elkadeem et al. · Current Cancer Drug Targets · 2019 · 47 citations

Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas

Sherif El Saadany, Taher El-Demerdash, Amal Helmy et al. · PubMed · 2018 · 28 citations

, , +14

Prevalence of iron deficiency anemia and beta thalassemia carriers among relatives of beta thalassemia patients in Nile Delta region, Egypt: a multicenter study

Mohamed El‐Shanshory, Laila M. Sherief, Hoda Hassab et al. · Journal of the Egyptian Public Health Association · 2021 · 19 citations · Full text

The interrelation between lipid profile in chronic HCV patients and their response to antiviral agents

Rasha Eletreby, Mahmoud Anees, Mariam Naguib et al. · Expert Review of Gastroenterology & Hepatology · 2020 · 14 citations

Copeptin as a novel marker predicting prognosis of liver cirrhosis and its major complications

Ahmed Tawfik, Amal Helmy, Mohamed Yousef et al. · Hepatic Medicine Evidence and Research · 2018 · 13 citations · Full text

1–5 of 6